JAMA article: "Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns." Published online December 22, 2025. Article discusses study design, participants, exposures, outcomes, and measures.
Newborn #nirsevimab immunization was associated with lower risks of RSV-related hospitalization and severe outcomes compared to maternal #RSVpreF vaccination.
ja.ma/4bj1lga
JAMA article "Interim Safety of RSVpreF Vaccination During Pregnancy," published online January 8, 2025. The article discusses respiratory syncytial virus and includes a table titled "Antenatal Testing and Risk of Stillbirth" listing tests, descriptions, patient populations.
#RSVpreF vaccination during late #pregnancy was not associated with increased risk of preterm birth or hypertensive disorders in interim safety analysis.
ja.ma/3Zg9Odu
A research letter from JAMA titled, "Interim Safety of RSVpreF Vaccination During Pregnancy". The article discusses respiratory syncytial virus(RSV) and includes a table about antenatal testing and risk of stillbirth.
#RSVpreF vaccination during late #pregnancy was not associated with increased risk of preterm birth or hypertensive disorders in interim safety analysis.
ja.ma/3LjUV6w
JAMA article "Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns." Published online December 22, 2025. Article discusses the effectiveness of infant immunization strategies for RSV.
Newborn #nirsevimab immunization was associated with lower risks of RSV-related hospitalization and severe outcomes compared to maternal #RSVpreF vaccination.
ja.ma/4pg9vtw
JAMA article "Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns." Published online December 22, 2025. Article discusses the effectiveness of infant immunization strategies for RSV.
From @jama.com: Newborn #nirsevimab immunization was associated with lower risks of RSV-related hospitalization and severe outcomes compared to maternal #RSVpreF vaccination.
ja.ma/3Y6uMed
JAMA article "Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns." Published online December 22, 2025. Article discusses the effectiveness of infant immunization strategies for RSV.
Newborn #nirsevimab immunization was associated with lower risks of RSV-related hospitalization and severe outcomes compared to maternal #RSVpreF vaccination.
ja.ma/45b5jEc
JAMA article "Nirsevimab vs RSVpreF Vaccine for Respiratory Syncytial Virus-Related Hospitalization in Newborns." Published online December 22, 2025. Article discusses the effectiveness of infant immunization strategies for RSV.
Newborn #nirsevimab immunization was associated with lower risks of RSV-related hospitalization and severe outcomes compared to maternal #RSVpreF vaccination.
ja.ma/44GMGI6
